A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
ReNeuron Group plc
Start Date
December 18, 2017
End Date
July 31, 2021
Administered By
Duke Clinical Research Institute
Awarded By
ReNeuron Group plc
Start Date
December 18, 2017
End Date
July 31, 2021